/ /

LATEST

Novel brolucizumab fosters as real-world alternative for nAMDTopline results from phase III studies investigating intravitreal brolucizumab (Novartis) for treatment of neovascular age-related macular degeneration (nAMD) support the potential of this novel anti-VEGF antibody to meet the real-world need for an alternative agent with a sustainable therapeutic regimen.
IOL-telescope may improve vision for patients with advanced maculopathiesTake-Home Message: The Telescopic Intra-Ocular Lens for Visually Impaired People Revolution system is promising to improve the vision in patients with maculopathies.
Why ophthalmologists are easy prey for cybercriminalsA perfect storm is brewing that may make ophthalmologists and office staff, with networked equipment, easy targets for cyber criminals. In a matter of days, cyber criminals can infect computers around the world. Sure, you can pay the ransom, but HIPAA fines and consultant fees, recovering from the damage to your reputation, loss of patients, and all the time and energy lost could bankrupt your practice.
Did JFK back pain cost his life?On Oct. 26, the federal government will release the last of the secret records on the Kennedy Assassination. Whatever revelations emerge from the estimated 3,600 files, one signature fact will remain: Lee Harvey Oswald was the lone gunman in Dealey Plaza. Still, new perspectives on the tragedy continue to surface, even after 50 years.
Connect with ARVO colleagues during AAO
AAO 2017: New solutions, New inspirations, New OrleansThe 2017 meeting of the American Academy of Ophthalmology will convene in New Orleans from Nov. 11 to 14. Go to www.aao.org/annual meeting for the latest updates
CXL demands continuity of careCrosslinking meets the previously unmet needs of progressive keratoconus patients and provides an opportunity to increase engagement with optometrists, explain John Berdahl, MD, and George O. Waring IV, MD.
Precision medicine coming to glaucoma via specific pathwaysCharacterizing the genetic elements linked to different types of glaucoma, such as in the Primary Open-Angle African American Glaucoma Genetics study, could help clinicians develop more precise and effective treatments.
Head to head: Balanced phaco tip more efficient than Kelman tipResearchers share findings from a comparison of relative efficiency and chatter of two phaco tips with identical optimal settings.
Applying hydrogel technology to sustained-release ocular drugsHydrogel technology enables the use of drugs that are known to be efficacious for ocular diseases and conditions when formulated as daily drops or monthly injections, into one-time or several-month dosage forms.

Poll

View Results